SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Eli Lilly Must Sell Dog Heartworm Line to Buy Novartis AG’s Animal Health Unit
December 23, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Vernalis PLC Stumbles As Novartis AG Abandons Work On AUY922
December 19, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Novartis AG Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment
December 16, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
FDA
FDA Approves Novartis AG Drug For Rare Hormonal Disorder
December 16, 2014
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Novartis AG-Backed Startup Annexon Bioscience Nabs $34 Million Series A
December 15, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG Psoriasis Drug Tops Johnson & Johnson’s Stelara In Late-Stage Study
December 12, 2014
 · 
1 min read
Job Trends
Novartis AG Announces Phase 3 Layoffs At Diovan Plant In New York
December 11, 2014
 · 
2 min read
Job Trends
Novartis AG Eliminating Up To 200 Jobs At U.S. Headquarters
December 8, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Array BioPharma, Inc. Regains Worldwide Rights To Cancer Drug From Novartis AG
December 4, 2014
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Uproar Over National Institute for Clinical Excellence (NICE) Rejection of Novartis AG MS Pill
August 5, 2011
 · 
1 min read
Policy
FDA Approves Supplemental New Drug Application for Novartis Pharmaceuticals Corporation Therapy Gilenya(TM) to Include Data Showing Reduction in T1 Lesions in MS, a Marker of Disease Activity
August 2, 2011
 · 
11 min read
Business
Novartis AG Ends Pursuit of Gen-Probe Incorporated
July 20, 2011
 · 
1 min read
Deals
Novartis AG Has No Need to Buy Intercell AG, According to Source
July 19, 2011
 · 
1 min read
FDA
National Institute for Clinical Excellence (NICE) Proposes to Disapprove the Use of the Drug Novartis AG’s Lucentis; Diabetes Groups Outraged
July 19, 2011
 · 
1 min read
Novartis AG New Drugs Help Fight Generics Threat
July 19, 2011
 · 
1 min read
The Week in Review: Will Novartis AG IPO in Shanghai?
July 18, 2011
 · 
1 min read
Job Trends
Novartis AG UK Workers Embroiled Over Severance Pay
July 15, 2011
 · 
1 min read
Policy
Novartis AG Eye Drug Rejected for Diabetic Use in UK
July 15, 2011
 · 
1 min read
Deals
Novartis AG Broods Over a China IPO, CEO Says Drugmaker is Ready for More Deals
July 12, 2011
 · 
1 min read
Load More